Company Active LTD

Company profile

Viridian Pharma Limited

Viridian Pharma Limited is a UK company with status active founded in 2002 based in London.

CRN
04398894
Founded
2002
Age
24

Overview

Legal name
VIRIDIAN PHARMA LIMITED
Region
London
Registered address
MARTINDALE PHARMA BAMPTON ROAD
HAROLD HILL
ROMFORD
ESSEX
ENGLAND
RM3 8UG
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Viridian Pharma Limited
CRN 04398894
2
Direct and ultimate controller Active LTD
Orphea Limited
CRN 10113308

Company events

Reference milestones and recent Companies House filing stream events.

9 events
08 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

25 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

30 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MTQ3MjYwOGFkaXF6a2N4

Published 30 Oct 2024 03:43

17 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzOTk3NDU2N2FkaXF6a2N4

Published 17 Oct 2024 03:53

17 Oct
2024

Appoint Person Secretary Company With Name Date

Officers

AP03 | Transaction MzQzOTk3NDU2OWFkaXF6a2N4

Published 17 Oct 2024 03:53

17 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzOTk3NDU2NGFkaXF6a2N4

Published 17 Oct 2024 03:53

20 Mar
2002

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2014
Funded years
2014
Age at first award
11 years

Projects

2014 Feasibility Studies Lead participant

Development of a novel membrane coating technology for the formulation of orally disintegrating tablets to deliver flucloxacillin

1 Feb 2014 to 30 Nov 2014

Awarded
£42,452
Total cost £56,602

Traditionally there has been a reluctance in the pharmaceutical industry to carry out clinical trials in children at the time of licensing. This has led to the scenario where many medicines are not specifically designed for use in children, which can result in poor effectiveness. To address this issue, the European Medicines Agency has recently issued a p...

Product types

Feasibility Studies